59.4%United States United States
8.7%United Kingdom United Kingdom
5%Canada Canada
4%Australia Australia
3.5%Philippines Philippines
2.6%Netherlands Netherlands
2.4%India India
1.6%Germany Germany
1%France France
0.7%Poland Poland

Today: 207
Yesterday: 251
This Week: 207
Last Week: 2221
This Month: 4795
Last Month: 6796
Total: 129394

CONTENTS

User Rating: / 0
PoorBest 
Reports - National Report Turkey 2006

Drug Abuse

CONTENTS

ABBREVIATIONS   

FOREWORD   

PART A
NEW DEVELOPMENTS AND TRENDS

1. NATIONAL POLICIES AND LEGISLATION   
1.1. Legal Framework        
1.1.1. Control over Legal Opium Poppy and Cannabis Production
1.1.2. Legal Trade of Controlled Substances and Preparations
1.1.3. Control of Chemicals/Narcotic Precursors Commonly Used or to be Potentially Used in the Manufacturing of Illicit Drugs and/or Psychotropic Substances
1.1.4. Probation
1.1.5. Health Care Services in the Penitentiary Institutions
1.1.6. Money Laundering
1.2. Institutional Organization, Strategies and Policies
1.2.1. International Cooperation
1.2.1.1. Liaison Officers
1.2.1.1.1. Foreign Liaison Officers Assigned to Turkey
1.2.1.1.2. Turkish Liaison Officers Assigned Abroad
1.2.2. National Plan and Strategies
1.2.2.1. Policy and Strategy Practice
1.2.2.1.1. Demand Reduction Activities
1.2.2.1.1.1.Controlled Delivery Operations
1.2.2.1.2. Demand Reduction Activities
1.2.2.2. Training Activities   
1.2.2.2.1. Turkish International Academy Against Drugs and Organized Crime (TADOC) and its Activities
1.3. Budget and Public Expenditure
1.4. Social and Cultural Context

2. DRUG USE IN THE POPULATION
2.1. Drug Use in Turkey   
2.2. Drug Use Habits
2.3. Drug Use at School and Among the Young Population   
2.4. Drug Use in Specific Groups

3. PREVENTION
3.1. General Prevention Activities
3.2. Selected/Specific Prevention Activities

4. PROBLEM DRUG USE
4.1. Estimation of Prevalence and Frequency
4.2. Treatment Demand Indicators
4.2.1. Profile of Drug Users under Treatment

5. DRUG-RELATED TREATMENT
5.1. Treatment System   
5.1.1. Aim of the Treatment   
5.1.2. Substitution Treatment   
5.1.3. Non-Substitution Treatment   

6. HEALTH CORRELATES AND CONSEQUENCES
6.1. Drug-related Deaths and Mortality of Drug Users
6.2. Drug-Related Infectious Diseases   
6.2.1. HIV/AIDS    
6.2.2. HEPATITIS B   
6.2.3. HEPATITIS C   
6.2.4. Tuberculosis   
6.3. Other Drug-Related Health Problems   

7. RESPONSES TO HEALTH CORRELATES AND CONSEQUENCES
7.1. Prevention of Drug-Related Deaths
7.2. Prevention and Treatment of Drug-Related Infectious Diseases   
7.3. Measures on Drug-Related Psychiatric Problems
7.4. Measures on Other Drug-Related Health Problems

8. SOCIAL CORRELATES AND CONSEQUENCES
8.1. Social Exclusion        
8.2. Drug-Related Crimes       
8.3. Drug Use in Prison       

9. RESPONSES TO SOCIAL CORRELATES AND CONSEQUENCES   
9.1. Social Re-integration       
9.2. Prevention of Drug-Related Crimes       

10. DRUG MARKETS   
10.1. Availability and Supply       
10.1.1. Geographical Location of Turkey in Terms of Drug Routes       
10.1.2. Evaluation In Terms of Main Drugs Affecting Turkey       
10.1.3. Evaluation In Terms of Chemical Substances Used in Drug Production   
10.2. Seizures       
10.3. Price / Purity        
10.3.1. Retail Sale prices       
10.3.2. Purity Ratios   

PART B   
SELECTED ISSUES   

11. DRUG USE AND RELATED PROBLEMS AMONG VERY YOUNG PEOPLE (<15 YEARS OF AGE)        

PART C   
BIBLIOGRAPHY, ANNEXES   
1. Bibliography       
2. Annexes       
3. Tables       
4. Graphics and Images